Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BHST vs MAMA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MAMA Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 9–1 Matrix Metrics)

MAMA Overall Winner 6-Pillar Tally: BHST 2 – 4 MAMA Matrix Metrics: BHST 1 – 9 MAMA

As of Nov 20, 2026, Mama's Creations, Inc. (MAMA) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BHST carries a Unified Composite Score of 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin), whereas MAMA carries 39.0/100 (SELL) at $11.08 (36.9x Forward P/E, 5.2% operating margin).

  • Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. MAMA 39.0/100 SELL), MAMA captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (5.2% vs. -18.0% operating margin) and revenue trajectory (+55.0% vs. +3.8% YoY).
  • Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile MAMA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BHST vs MAMA
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
TTM Revenue $35M
Forward P/E N/M
Beta / 30D Vol 0.25β · 86% Vol
Unified Composite Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $1.55 · SMA50: $1.58
MAMA NASDAQ Head-to-Head Winner
Mama's Creations, Inc. Common Stock
Sausages & Other Prepared Meat Products
$11.08
-1.42% 1D
Market Cap $529.9M
TTM Revenue $209M
Forward P/E 36.9x
Beta / 30D Vol 0.79β · 50% Vol
Unified Composite Score
39.0 / 100 SELL
Tech 30.0 Fund 49.0 Flow 65.0 Mom 49.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.3%), weak momentum, RSI 31
RSI-14: 30.8 · SMA20: $12.72 · SMA50: $13.02

6-Pillar Scorecard Institutional Category Breakdown (BHST 2 – 4 MAMA)

Columns: Metric · BHST · MAMA
1. Valuation Multiples MAMA
Forward P/E N/M 36.9x
Trailing P/E N/M 70.2x
PEG Ratio N/M N/M
EV / Revenue 0.7x 1.9x
2. Growth & Scale MAMA
Revenue Growth (YoY) +3.8% +55.0%
Earnings Growth (YoY) +0.0% +100.0%
TTM Revenue (USD) $35M $209M
Market Cap $29.9M $529.9M
3. Profitability & Quality MAMA
Gross Margin 59.0% 24.3%
Operating Margin -18.0% 5.2%
Net Profit Margin -31.2% 3.5%
Return on Equity (ROE) -142.5% 7.5%
4. Balance Sheet & Cash Flow MAMA
Cash Generation (TTM) -$9.4M $17M
Cash Flow Margin -26.6% 8.3%
Net Cash / Leverage $5.1M Net Cash $126M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning BHST
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 50.9% (28th %ile)
Put/Call OI Skew N/A 0.03x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat BHST
OpEx & R&D Intensity 77.0% of Rev ($27M) 19.1% of Rev ($40M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BHST (1) vs MAMA (9)
Institutional Metric BHST MAMA Criterion Row Edge
Market Capitalization
Scale
$29.9M $529.9M Larger Scale MAMA
Trailing P/E Ratio
Valuation
N/M 70.2x Lower Multiple MAMA
Forward P/E Ratio
Valuation
N/M 36.9x Lower Multiple MAMA
Revenue Growth (YoY)
Growth
+3.8% +55.0% Higher Growth MAMA
Operating Margin (TTM)
Profitability
-18.0% 5.2% Higher Margin MAMA
Net Profit Margin
Profitability
-31.2% 3.5% Higher Margin MAMA
Return on Equity (ROE)
Capital Efficiency
-142.5% 7.5% Higher ROE MAMA
52-Week Range Position
Momentum
6% ($1–$7) 10% ($10–$21) Stronger Trend MAMA
Beta / 30D Volatility
Risk Regime
0.25β · 86% Vol 0.79β · 50% Vol Lower Realized Risk MAMA
Unified Institutional Score
Composite Signal
58.2 / 100 (HOLD) 39.0 / 100 (SELL) Higher Composite BHST
Trailing 12M Revenue (USD)
Operating Scale
$35M $209M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
59.0% 24.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.7x EV/Rev N/M PEG · 1.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$9.4M ($5.1M Net Cash) $17M ($126M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MAMA +6.12 pp
BHST: -22.62% · MAMA: -16.5%
3M Horizon MAMA +3.74 pp
BHST: -36.59% · MAMA: -32.85%
6M Horizon MAMA +41.13 pp
BHST: -66.32% · MAMA: -25.19%
1Y Horizon MAMA +89.32 pp
BHST: -79.4% · MAMA: +9.92%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period BHST Revenue MAMA Revenue BHST Op. Margin MAMA Op. Margin Margin Leader
FY2019 N/A $30M N/A 5.2% MAMA
FY2020 N/A $30M N/A 6.2% MAMA
FY2021 N/A $40M N/A 8.5% MAMA
FY2022 N/A $50M N/A 0.2% MAMA
FY2023 $10M $90M -78.6% 3.0% MAMA
FY2024 $30M $100M -27.7% 8.6% MAMA
FY2025 $30M $120M -16.2% 4.0% MAMA
FY2026 N/A $170M N/A 4.1% MAMA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BHST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MAMA BREAKDOWN
102d in phase · OBV DISTRIBUTION
Current IV 50.9%
IV Percentile 28th %ile
Put/Call OI Skew 0.03x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact MAMA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BHST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $29.9M market capitalization and -18.0% operating margin.
OpEx & R&D Reinvestment 77.0% of Rev ($27M)
90D Engineering Disclosures 0 Published
MAMA Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $529.9M market capitalization and 5.2% operating margin.
OpEx & R&D Reinvestment 19.1% of Rev ($40M)
90D Engineering Disclosures 0 Published

Investor FAQ BHST vs MAMA Key Questions & Quantitative Answers

As of Nov 20, 2026, Mama's Creations, Inc. (MAMA) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BHST carries a Unified Composite Score of 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin), whereas MAMA carries 39.0/100 (SELL) at $11.08 (36.9x Forward P/E, 5.2% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. MAMA 39.0/100 SELL), MAMA captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (5.2% vs. -18.0% operating margin) and revenue trajectory (+55.0% vs. +3.8% YoY). Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile MAMA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MAMA leads the Growth & Scale pillar: BHST posts +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin), compared with MAMA at +55.0% YoY revenue growth and +100.0% YoY earnings growth on $209M TTM revenue (24.3% gross margin, 5.2% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), BHST cumulative revenue shifted +200.0% while MAMA shifted +466.7%. In operating R&D and SG&A reinvestment, BHST deploys 77.0% of Rev ($27M) (0 90-day corporate R&D disclosures) versus 19.1% of Rev ($40M) (0 disclosures) for MAMA.

MAMA screens cheaper on headline valuation multiples. BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin), whereas MAMA trades at 36.9x Forward P/E, 70.2x Trailing P/E, N/M PEG, and 1.9x EV/Revenue (8.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHST (-142.5% ROE) versus MAMA (7.5% ROE) capital efficiency.

In options market volatility and institutional positioning, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk). By comparison, MAMA carries 50.9% implied volatility (28th %ile, Balanced (25th–60th %ile)), a 0.03x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.79β · 50% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.